AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

TELIX PHARMACEUTICALS LTD

15.720

-0.430-2.66%

Volume:2.53M

Turnover:40.13M

Market Cap:5.32B

PE:114.46

High:16.300

Open:16.300

Low:15.700

Close:16.150

52wk High:18.220

52wk Low:8.260

Shares:338.72M

Float Shares:275.41M

Volume Ratio:1.21

T/O Rate:0.92%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.137

EPS(LYR):-0.030

ROE:7.36%

ROA:2.71%

PB:7.58

PE(LYR):-517.45

Loading ...

Overview Company News Filings

Jefferies Raises PT on Australia's Telix Pharma After Deal with ITM Isotope Technologies

Telix Wins FDA Fast Track for BiPASS Pre-Biopsy Prostate Cancer Imaging Study

Telix Pharmaceuticals - Illuccix and Gozellix Approved for Pet Imaging of Psma-Positive Prostate Cancer Lesions

THOMSON REUTERS

Telix Pharmaceuticals Limited-FDA Fast Track for Bipass Pre Biopsy Prostate Imaging

THOMSON REUTERS

Australia's Telix Pharmaceuticals to End Week Lower as ITM Deal Weigh

Capmont Sells ITM Stake as Telix Agrees US$ 1.65 Billion Acquisition

Telix Pharma Rises After ITM Deal Selloff; Citi Backs Share Issuance

Telix Pharmaceuticals Receives ASX Waivers on Share Issuance Timing for Acquisition Consideration

MT Newswires Live

Telix Pharmaceuticals Limited-Grant of Waivers of Listing Rule 7.3.4

THOMSON REUTERS

France's Abivax H1 Net Loss Widens on Higher Expenses Driven by Clinical Programs

Deals of the Day-Mergers and Acquisitions

Australian Shares End Flat as Miners Offset Gains in Banks

Australian Shares Flat; Telix Pharmaceuticals to Acquire German Radiopharmaceutical Biotechnology Company for Initial $1.65 Billion Payment

MT Newswires Live

Australia's Telix Falls as Investors Focus on Dilution Risks in ITM Deal

Telix's $50 Mln Synergies Look Good to Bulls

Telix's $2.35b Acquisition Makes Strategic Sense

Telix Pharmaceuticals Announces Shareholder Meeting

Australia Shares Set to Resume Recent Slide

Australia's Telix Pharma Agrees to Buy Germany's ITM Isotope for About $1.65 Billion

Telix Pharmaceuticals Limited - Telix and Itm Join Forces to Create Radiopharma Powerhouse

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/TLX.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TLX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"TLX.AU\",,,,,undefined,":{"symbol":"TLX.AU","market":"AU","secType":"STK","nameCN":"TELIX PHARMACEUTICALS LTD","latestPrice":15.72,"timestamp":1790748720000,"preClose":16.15,"halted":0,"volume":2533433,"delay":0,"changeRate":-0.0266253869969039,"nameEN":"TELIX PHARMACEUTICALS LTD","floatShares":275410996,"shares":338721355,"eps":0.13733634922531793,"marketStatus":"Not Yet Opened","change":-0.43,"latestTime":"09-30 16:12:00 AEST","open":16.3,"high":16.3,"low":15.7,"amount":40128538,"amplitude":0.037152,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.13733634922531793,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1790812800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":16.15,"openAndCloseTimeList":[[1790726400000,1790748000000]],"volumeRatio":1.2116318393375947,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"TLX.AU","preClose":15.72,"auctionPrice":15.8,"auctionVolume":2189,"auctionTime":1790808306506,"referenceTime":1790764203089,"auction":1,"marketStatus":"盘前竞价","timestamp":1790808306506}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"TLX.AU\",,,,,undefined,":{"symbol":"TLX.AU","floatShares":275410996,"roa":"2.71%","roe":"7.36%","lyrEps":-0.03038,"volumeRatio":1.2116318393375947,"shares":338721355,"dividePrice":0,"high":16.3,"amplitude":0.037152,"preClose":16.15,"low":15.7,"week52Low":8.26,"pbRate":"7.58","psRate":"4.15","week52High":18.22,"institutionHeld":0,"latestPrice":15.72,"eps":0.13733634922531793,"divideRate":0,"volume":2533433,"delay":0,"ttmEps":0.13733634922531793,"open":16.3,"prevYearClose":11.2,"prevWeekClose":15.9,"prevMonthClose":15.72,"prevQuarterClose":15.72,"fiveDayClose":16.08,"twentyDayClose":15.69,"sixtyDayClose":16.58},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TLX.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-20","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787184000000,"name":null,"time":"","dateTimestamp":1787148000000,"actualEps":null},{"date":"2026-02-19","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771455600000,"name":null,"time":"","dateTimestamp":1771419600000,"actualEps":null},{"date":"2026-01-19","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1768777200000,"name":null,"time":"","dateTimestamp":1768741200000,"actualEps":null},{"date":"2025-08-21","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755734400000,"name":null,"time":"","dateTimestamp":1755698400000,"actualEps":null},{"date":"2025-02-19","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1739919600000,"name":null,"time":"","dateTimestamp":1739883600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TLX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TLX.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672178482","title":"Jefferies Raises PT on Australia's Telix Pharma After Deal with ITM Isotope Technologies","url":"https://stock-news.laohu8.com/highlight/detail?id=2672178482","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672178482?lang=en_us&edition=fundamental","pubTime":"2026-10-01 03:04","pubTimestamp":1790795080,"startTime":"0","endTime":"0","summary":"BUZZ-Jefferies raises PT on Australia's Telix Pharma after deal with ITM Isotope Technologies** Jefferies upgrades price target on Telix PharmaceuticalsTLX.AXto A$32 from A$30** Last week, co said it ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nL4N45M1NF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671357228","title":"Telix Wins FDA Fast Track for BiPASS Pre-Biopsy Prostate Cancer Imaging Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2671357228","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671357228?lang=en_us&edition=fundamental","pubTime":"2026-09-30 06:31","pubTimestamp":1790721117,"startTime":"0","endTime":"0","summary":"Telix wins FDA Fast Track for BiPASS pre-biopsy prostate cancer imaging studyTelix received FDA Fast Track designation for BiPASS, a Phase 3 program testing 68Ga PSMA-PET with MRI before prostate biop","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDL8KhHrF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671288372","title":"Telix Pharmaceuticals - Illuccix and Gozellix Approved for Pet Imaging of Psma-Positive Prostate Cancer Lesions","url":"https://stock-news.laohu8.com/highlight/detail?id=2671288372","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671288372?lang=en_us&edition=fundamental","pubTime":"2026-09-30 06:21","pubTimestamp":1790720514,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUE2DKRGG:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TLX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671228833","title":"Telix Pharmaceuticals Limited-FDA Fast Track for Bipass Pre Biopsy Prostate Imaging","url":"https://stock-news.laohu8.com/highlight/detail?id=2671228833","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671228833?lang=en_us&edition=fundamental","pubTime":"2026-09-30 06:21","pubTimestamp":1790720514,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUE2DKRGG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TLX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670412960","title":"Australia's Telix Pharmaceuticals to End Week Lower as ITM Deal Weigh","url":"https://stock-news.laohu8.com/highlight/detail?id=2670412960","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670412960?lang=en_us&edition=fundamental","pubTime":"2026-09-25 11:14","pubTimestamp":1790306097,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Telix Pharmaceuticals to end week lower as ITM deal weigh** Shares of Telix PharmaceuticalsTLX.AXup 2.2%; shed 10% for the week so far, on track for its worst week since early Feb, if","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nL4N45H04U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669930274","title":"Capmont Sells ITM Stake as Telix Agrees US$ 1.65 Billion Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2669930274","media":"Reuters","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669930274?lang=en_us&edition=fundamental","pubTime":"2026-09-24 21:22","pubTimestamp":1790256127,"startTime":"0","endTime":"0","summary":"Capmont sells ITM stake as Telix agrees US$ 1.65 billion acquisitionCapmont sold its minority stake in portfolio company ITM Isotope Technologies Munich as part of ITM’s merger with Telix Pharmaceutic","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nNDL4NY2qh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","TLX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669948741","title":"Telix Pharma Rises After ITM Deal Selloff; Citi Backs Share Issuance","url":"https://stock-news.laohu8.com/highlight/detail?id=2669948741","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669948741?lang=en_us&edition=fundamental","pubTime":"2026-09-22 08:59","pubTimestamp":1790038778,"startTime":"0","endTime":"0","summary":"BUZZ-Telix Pharma rises after ITM deal selloff; Citi backs share issuance** Shares of Telix PharmaceuticalsTLX.AXrise as much as 6.8% to A$16.83, their biggest intraday pct gain since September 15** S","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nL4N45E019:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4504","BK7067","LU0130517989.USD","LU2360032135.SGD","LU2456880835.USD","LU0128525689.USD","LU0162691827.USD","BK4559","LU2417539215.USD","IE00BSNM7G36.USD","LU2125154935.USD","LU0106831901.USD","LU0052756011.USD","LU2462157665.USD","LU2236285917.USD","FTXO","BK4207","LU1162221912.USD","LU0203347892.USD","BK4566","BK4588","TLX.AU","LU1074936037.SGD","LU1506573853.SGD","LU0072461881.USD","LU0314106906.USD","LU1201861249.SGD","LU0980610538.SGD","LU0098860793.USD","IYF","LU1366192091.USD","LU0203345920.USD","LU0320765646.SGD","TFNS","LU0648001328.SGD","LU0130102774.USD","LU1267930227.SGD","LU0170899867.USD","LU0477156953.USD","BK4585","LU0310800965.SGD","LU1244550577.SGD","LU2125154778.USD","LU1244550221.USD","LU1244550494.USD","BK4534","LU1668664300.SGD","LU1144417596.USD","LU1791807156.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669196280","title":"Telix Pharmaceuticals Receives ASX Waivers on Share Issuance Timing for Acquisition Consideration","url":"https://stock-news.laohu8.com/highlight/detail?id=2669196280","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669196280?lang=en_us&edition=fundamental","pubTime":"2026-09-22 07:25","pubTimestamp":1790033141,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals  sought waivers of an ASX rule to allow shares issued as upfront consideration and future consideration to be issued more than three months after its extraordinary general meeting, as the timing is contingent on completion of closing conditions and achievement of specific milestones, according to a Tuesday Australian bourse filing.The company said ASX granted the waivers, with certain conditions, including that shares tied to the upfront payment are issued once the relevant deal conditions are met, and in any case no later than 12 months after shareholders approve the issue.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","TLX.AU","TLX","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669195750","title":"Telix Pharmaceuticals Limited-Grant of Waivers of Listing Rule 7.3.4","url":"https://stock-news.laohu8.com/highlight/detail?id=2669195750","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669195750?lang=en_us&edition=fundamental","pubTime":"2026-09-22 06:24","pubTimestamp":1790029451,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nTUE5NX0VJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TLX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669716198","title":"France's Abivax H1 Net Loss Widens on Higher Expenses Driven by Clinical Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2669716198","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669716198?lang=en_us&edition=fundamental","pubTime":"2026-09-22 04:27","pubTimestamp":1790022476,"startTime":"0","endTime":"0","summary":"France's Abivax H1 net loss widens on higher expenses driven by clinical programsOverviewFrance biotechnology firm's H1 2026 net loss widened as operating expenses increasedCompany completed royalty c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nL1N45D0VO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","TLX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669168153","title":"Deals of the Day-Mergers and Acquisitions","url":"https://stock-news.laohu8.com/highlight/detail?id=2669168153","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669168153?lang=en_us&edition=fundamental","pubTime":"2026-09-21 19:37","pubTimestamp":1789990641,"startTime":"0","endTime":"0","summary":"Deals of the day-Mergers and acquisitionsSept 21 (Reuters)-The following bids, mergers, acquisitions and disposals were reported by 0930 GMT on Monday:** US spirits maker Sazerac launched a takeover o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nL6N45D0CA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX.AU","BK0182","BK1190","BK0084","BK0070","600392","BK1513","BK0233","BK7067","00769","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669531491","title":"Australian Shares End Flat as Miners Offset Gains in Banks","url":"https://stock-news.laohu8.com/highlight/detail?id=2669531491","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669531491?lang=en_us&edition=fundamental","pubTime":"2026-09-21 15:25","pubTimestamp":1789975555,"startTime":"0","endTime":"0","summary":"Australian shares end flat as miners offset gains in banksSept 21 (Reuters)-Australian shares ended little changed on Monday as gains in financials offset losses in commodity stocks, while expectation","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nL4N45D0BL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0264606111.USD","LU1309081286.SGD","LU1046248800.SGD","LU0831103253.SGD","IE00BQJZX424.USD","SG9999001143.SGD","LU0345777147.USD","LU0330918003.SGD","BHP.AU","CSL.AU","LU0971552673.USD","LU0612318971.USD","LU1064927863.SGD","LU0898667661.SGD","LU0456854461.SGD","RIO.UK","LU0345781412.USD","LU0011963245.USD","ANZ.AU","RIO.AU","LU1302929846.USD","LU0266512473.USD","LU1487256676.USD","LU0171293334.USD","BK7067","COH.AU","LU0572939691.SGD","LU0955623706.USD","LU1481599808.USD","BK7007","AN3PL.AU","BK7511","LU0075056555.USD","LU1078025761.USD","IE00BWDBJ516.SGD","BK7508","LU1430597077.USD","LU0654597011.USD","LU0955648018.USD","LU0788109121.HKD","LU1023059493.AUD","TLX.AU","LU1481600234.SGD","CBA.AU","BK5111","SG9999002521.SGD","LU0345777659.USD","LU1130305938.SGD","LU2463526074.USD","LU0955669360.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669015836","title":"Australian Shares Flat; Telix Pharmaceuticals to Acquire German Radiopharmaceutical Biotechnology Company for Initial $1.65 Billion Payment","url":"https://stock-news.laohu8.com/highlight/detail?id=2669015836","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669015836?lang=en_us&edition=fundamental","pubTime":"2026-09-21 14:37","pubTimestamp":1789972642,"startTime":"0","endTime":"0","summary":"Australian shares were flat on Monday, as oil prices eased despite heightened tensions in the Middle East.The S&P/ASX 200 Index was little changed to close at 8,731.90.Brent crude oil futures fell to ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SLF.AU","DACE.AU","LU0757428866.USD","IOZ.AU","TLX.AU","IMLC.AU","XJO.AU","EIGA.AU","ZYAU.AU","BK4139","BEAR.AU","STW.AU","XAO.AU","PPT.AU","BK7506","BK7067","BK4137","QRE.AU","E200.AU","IIGF.AU","IISV.AU","GEAR.AU","QFN.AU","BBOZ.AU","RMS.AU","XKO.AU","BK7062","VAP.AU","BK7104","OZR.AU","VAS.AU","OZF.AU","GIVE.AU","LU1303367103.USD","RBA","LU1815336091.USD","TLX","LU2098885051.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669372541","title":"Australia's Telix Falls as Investors Focus on Dilution Risks in ITM Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2669372541","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669372541?lang=en_us&edition=fundamental","pubTime":"2026-09-21 13:49","pubTimestamp":1789969757,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Telix falls as investors focus on dilution risks in ITM deal** Shares of Telix PharmaceuticalsTLX.AXfall as much as 10.2% to A$16.030, logging their biggest intraday pct fall since Au","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nL4N45D0AZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669344501","title":"Telix's $50 Mln Synergies Look Good to Bulls","url":"https://stock-news.laohu8.com/highlight/detail?id=2669344501","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669344501?lang=en_us&edition=fundamental","pubTime":"2026-09-21 11:54","pubTimestamp":1789962840,"startTime":"0","endTime":"0","summary":"0354 GMT - The potential for US$50 million in cost synergies jumps out at UBS analysts as a key attraction of Telix Pharmaceuticals' US$2.35 billion acquisition of isotope manufacturer ITM. The analysts, who have a last-published buy rating on Telix's Australia-listed stock, tell clients in a note that the vertical integration of Telix with a supplier of key therapeutic isotopes strengthens its platform. They point out that ITM sits within a commercially validated category, with global annual sales of US$800 million for approved somatostatin receptor-targeted radioligand therapies. UBS has a target price of 22.00 Australian dollars on the stock, which is down 5.4% at A$16.88.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669134381","title":"Telix's $2.35b Acquisition Makes Strategic Sense","url":"https://stock-news.laohu8.com/highlight/detail?id=2669134381","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669134381?lang=en_us&edition=fundamental","pubTime":"2026-09-21 11:34","pubTimestamp":1789961640,"startTime":"0","endTime":"0","summary":"0334 GMT - Telix Pharmaceuticals' US$2.35 billion acquisition of ITM gives the Australian company unparalleled exposure to the supply chain for cancer treatments' dominant therapeutic isotope, Bell Potter analyst John Hester says. Hester highlights to clients in a note ITM's position as a leading manufacturer of isotopes including 177Lu, which he points out is used in treatments including Novartis's Pluvicto. With margins on ITM's isotope production well in advance of TLX's margins on its manufacturing, his initial view is that the acquisition makes a lot of strategic sense. Bell Potter is reviewing its forecasts for Telix and its target price on the stock. Shares are down 5.1% at 16.94 Australian dollars.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Telix's $2.35b Acquisition Makes Strategic Sense","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669136711","title":"Telix Pharmaceuticals Announces Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2669136711","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669136711?lang=en_us&edition=fundamental","pubTime":"2026-09-21 09:56","pubTimestamp":1789955791,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals announces shareholder meetingTelix Pharmaceuticals will hold an extraordinary general meeting in November 2026.Shareholders will vote on the proposed merger to acquire ITM Isotop","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nNDLbGJGlX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669387401","title":"Australia Shares Set to Resume Recent Slide","url":"https://stock-news.laohu8.com/highlight/detail?id=2669387401","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669387401?lang=en_us&edition=fundamental","pubTime":"2026-09-21 07:51","pubTimestamp":1789948260,"startTime":"0","endTime":"0","summary":"2351 GMT - Australian stocks look set to resume their recent slide in early trade, adding to losses compiled across three consecutive weekly declines. ASX futures are down by almost 0.7% ahead of Monday's session, suggesting that the S&P/ASX 200 will extend the 3.8% decline recorded so far in September. Investors are waiting on next week's Reserve Bank meeting, which is expected to end with an interest-rate increase and hawkish commentary on the potential for further increases. Ahead of Monday's open, Perpetual rejected EQT AB's best and final takeover proposal, Ingenia rejected Warburg Pincus's improved offer, and Telix Pharmaceuticals agreed to buy isotope supplier ITM for up to US$2.35 billion. Resolute Mining downgraded its 2026 gold production and cost guidance on challenges in Mali.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7506","RSG.AU","BK7067","BK7104","BK7062","PPT.AU","TLX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669018008","title":"Australia's Telix Pharma Agrees to Buy Germany's ITM Isotope for About $1.65 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2669018008","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669018008?lang=en_us&edition=fundamental","pubTime":"2026-09-21 06:55","pubTimestamp":1789944927,"startTime":"0","endTime":"0","summary":"Australia's Telix Pharma agrees to buy Germany's ITM Isotope for about $1.65 billionSept 21 (Reuters)-Australia's Telix PharmaceuticalsTLX.AXsaid on Monday it has agreed to acquire Germany-based ITM I","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260920:nL1N45C06M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","TLX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669804721","title":"Telix Pharmaceuticals Limited - Telix and Itm Join Forces to Create Radiopharma Powerhouse","url":"https://stock-news.laohu8.com/highlight/detail?id=2669804721","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669804721?lang=en_us&edition=fundamental","pubTime":"2026-09-21 06:38","pubTimestamp":1789943881,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260920:nFWN45A0PK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TLX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":199,"code":"91000000","status":"200"}]}}